SC 13G Filing

Company

Altimmune, Inc.

Filed

July 7, 2022

Accession Number

0000929638-22-001137

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →